

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.12757826 |
| 2 | chaperone-mediated protein transport (GO:0072321) | 5.33372548 |
| 3 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.30646026 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.13748946 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.13748946 |
| 6 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.65345548 |
| 7 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.41842045 |
| 8 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.36690925 |
| 9 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.34936613 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.27172899 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.27172899 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.27172899 |
| 13 | negative regulation of ligase activity (GO:0051352) | 4.23978008 |
| 14 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.23978008 |
| 15 | rRNA modification (GO:0000154) | 4.17949881 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.13973818 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 4.08233560 |
| 18 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.05175511 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.03612428 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 4.03612428 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.94173820 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 3.94173820 |
| 23 | protein targeting to mitochondrion (GO:0006626) | 3.89225904 |
| 24 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.86524749 |
| 25 | protein deneddylation (GO:0000338) | 3.80684751 |
| 26 | kynurenine metabolic process (GO:0070189) | 3.79969162 |
| 27 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.79569242 |
| 28 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.79569242 |
| 29 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.79569242 |
| 30 | establishment of integrated proviral latency (GO:0075713) | 3.78682032 |
| 31 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.78032674 |
| 32 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.78032674 |
| 33 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.77758813 |
| 34 | cullin deneddylation (GO:0010388) | 3.75997024 |
| 35 | inner mitochondrial membrane organization (GO:0007007) | 3.70280438 |
| 36 | ribosomal small subunit assembly (GO:0000028) | 3.69655431 |
| 37 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.67810989 |
| 38 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.67810989 |
| 39 | ribosomal large subunit biogenesis (GO:0042273) | 3.66041506 |
| 40 | protein localization to mitochondrion (GO:0070585) | 3.64398321 |
| 41 | establishment of protein localization to mitochondrion (GO:0072655) | 3.62903622 |
| 42 | NAD biosynthetic process (GO:0009435) | 3.62563207 |
| 43 | proteasome assembly (GO:0043248) | 3.61785986 |
| 44 | positive regulation of ligase activity (GO:0051351) | 3.61686114 |
| 45 | ribosome assembly (GO:0042255) | 3.61260145 |
| 46 | ubiquinone biosynthetic process (GO:0006744) | 3.59725389 |
| 47 | quinone biosynthetic process (GO:1901663) | 3.59725389 |
| 48 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.59247031 |
| 49 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.58308741 |
| 50 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.58308741 |
| 51 | protein complex biogenesis (GO:0070271) | 3.51128979 |
| 52 | branched-chain amino acid catabolic process (GO:0009083) | 3.49438508 |
| 53 | ubiquinone metabolic process (GO:0006743) | 3.49177315 |
| 54 | amine catabolic process (GO:0009310) | 3.47261842 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 3.47261842 |
| 56 | glyoxylate metabolic process (GO:0046487) | 3.45599751 |
| 57 | protein neddylation (GO:0045116) | 3.45381638 |
| 58 | rRNA methylation (GO:0031167) | 3.44549362 |
| 59 | aldehyde catabolic process (GO:0046185) | 3.41650934 |
| 60 | tricarboxylic acid cycle (GO:0006099) | 3.39635713 |
| 61 | purine nucleobase biosynthetic process (GO:0009113) | 3.37977558 |
| 62 | respiratory chain complex IV assembly (GO:0008535) | 3.36298703 |
| 63 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.35866929 |
| 64 | pseudouridine synthesis (GO:0001522) | 3.35235587 |
| 65 | regulation of mitochondrial translation (GO:0070129) | 3.33766174 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.33647868 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.33647868 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 3.33647868 |
| 69 | translation (GO:0006412) | 3.31700865 |
| 70 | tRNA methylation (GO:0030488) | 3.26859779 |
| 71 | heart contraction (GO:0060047) | 3.26601038 |
| 72 | heart process (GO:0003015) | 3.26601038 |
| 73 | establishment of viral latency (GO:0019043) | 3.25457609 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.24441655 |
| 75 | regulation of ligase activity (GO:0051340) | 3.24155189 |
| 76 | cytochrome complex assembly (GO:0017004) | 3.23890784 |
| 77 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.23588669 |
| 78 | mitochondrial transport (GO:0006839) | 3.20236211 |
| 79 | cellular component biogenesis (GO:0044085) | 3.19872565 |
| 80 | aromatic amino acid family metabolic process (GO:0009072) | 3.19331267 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.18087988 |
| 82 | regulation of cellular amine metabolic process (GO:0033238) | 3.14720008 |
| 83 | maturation of SSU-rRNA (GO:0030490) | 3.13748399 |
| 84 | bile acid biosynthetic process (GO:0006699) | 3.12916106 |
| 85 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.11613754 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.10678540 |
| 87 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.07889923 |
| 88 | spliceosomal snRNP assembly (GO:0000387) | 3.07195475 |
| 89 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.07102171 |
| 90 | cotranslational protein targeting to membrane (GO:0006613) | 3.05997152 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.05448244 |
| 92 | protein maturation by protein folding (GO:0022417) | 3.05130571 |
| 93 | oxidative phosphorylation (GO:0006119) | 3.04748311 |
| 94 | nucleobase biosynthetic process (GO:0046112) | 3.03395188 |
| 95 | amino acid salvage (GO:0043102) | 3.02799059 |
| 96 | L-methionine salvage (GO:0071267) | 3.02799059 |
| 97 | L-methionine biosynthetic process (GO:0071265) | 3.02799059 |
| 98 | polyketide metabolic process (GO:0030638) | 3.02325985 |
| 99 | doxorubicin metabolic process (GO:0044598) | 3.02325985 |
| 100 | daunorubicin metabolic process (GO:0044597) | 3.02325985 |
| 101 | protein targeting to ER (GO:0045047) | 3.02041188 |
| 102 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.01183915 |
| 103 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.01183915 |
| 104 | regulation of cholesterol esterification (GO:0010872) | 3.00810325 |
| 105 | amino-acid betaine metabolic process (GO:0006577) | 3.00395576 |
| 106 | iron-sulfur cluster assembly (GO:0016226) | 3.00059273 |
| 107 | metallo-sulfur cluster assembly (GO:0031163) | 3.00059273 |
| 108 | glycine metabolic process (GO:0006544) | 2.99615449 |
| 109 | DNA deamination (GO:0045006) | 2.97472850 |
| 110 | CENP-A containing nucleosome assembly (GO:0034080) | 2.96537783 |
| 111 | ribosomal small subunit biogenesis (GO:0042274) | 2.96387770 |
| 112 | cellular glucuronidation (GO:0052695) | 2.96211718 |
| 113 | branched-chain amino acid metabolic process (GO:0009081) | 2.95823809 |
| 114 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.95794779 |
| 115 | negative regulation of protein ubiquitination (GO:0031397) | 2.95222384 |
| 116 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.94782519 |
| 117 | formation of translation preinitiation complex (GO:0001731) | 2.94673078 |
| 118 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.94018690 |
| 119 | protein localization to endoplasmic reticulum (GO:0070972) | 2.93986665 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.93864839 |
| 121 | hydrogen ion transmembrane transport (GO:1902600) | 2.91775905 |
| 122 | ATP biosynthetic process (GO:0006754) | 2.90951856 |
| 123 | rRNA processing (GO:0006364) | 2.90610313 |
| 124 | maturation of 5.8S rRNA (GO:0000460) | 2.90226288 |
| 125 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.89530113 |
| 126 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.89143138 |
| 127 | tRNA aminoacylation for protein translation (GO:0006418) | 2.88944557 |
| 128 | cellular respiration (GO:0045333) | 2.88682008 |
| 129 | respiratory electron transport chain (GO:0022904) | 2.88201517 |
| 130 | tRNA aminoacylation (GO:0043039) | 2.87151699 |
| 131 | amino acid activation (GO:0043038) | 2.87151699 |
| 132 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.87145892 |
| 133 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.85445082 |
| 134 | chromatin remodeling at centromere (GO:0031055) | 2.85118066 |
| 135 | quinone metabolic process (GO:1901661) | 2.85095668 |
| 136 | serine family amino acid catabolic process (GO:0009071) | 2.84776274 |
| 137 | positive regulation of cell cycle arrest (GO:0071158) | 2.84451330 |
| 138 | intracellular protein transmembrane import (GO:0044743) | 2.83132730 |
| 139 | NAD metabolic process (GO:0019674) | 2.82289927 |
| 140 | omega-hydroxylase P450 pathway (GO:0097267) | 2.78634520 |
| 141 | uronic acid metabolic process (GO:0006063) | 2.78118428 |
| 142 | glucuronate metabolic process (GO:0019585) | 2.78118428 |
| 143 | electron transport chain (GO:0022900) | 2.76622571 |
| 144 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.76578620 |
| 145 | termination of RNA polymerase III transcription (GO:0006386) | 2.76578620 |
| 146 | coenzyme catabolic process (GO:0009109) | 2.76531469 |
| 147 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.75957048 |
| 148 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.75957048 |
| 149 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.75792057 |
| 150 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.75234194 |
| 151 | tyrosine metabolic process (GO:0006570) | 2.74633432 |
| 152 | alpha-amino acid catabolic process (GO:1901606) | 2.74134231 |
| 153 | fatty acid beta-oxidation (GO:0006635) | 2.73641753 |
| 154 | signal peptide processing (GO:0006465) | 2.72931567 |
| 155 | serine family amino acid metabolic process (GO:0009069) | 2.72371479 |
| 156 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.70902075 |
| 157 | response to nitrosative stress (GO:0051409) | 2.70837784 |
| 158 | L-serine metabolic process (GO:0006563) | 2.70808478 |
| 159 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70201511 |
| 160 | carnitine metabolic process (GO:0009437) | 2.68157436 |
| 161 | nucleotide transmembrane transport (GO:1901679) | 2.66671139 |
| 162 | cofactor catabolic process (GO:0051187) | 2.66546319 |
| 163 | methionine metabolic process (GO:0006555) | 2.63969012 |
| 164 | low-density lipoprotein particle remodeling (GO:0034374) | 2.63689416 |
| 165 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.62713626 |
| 166 | methionine biosynthetic process (GO:0009086) | 2.57325420 |
| 167 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.54283287 |
| 168 | protein carboxylation (GO:0018214) | 2.54283287 |
| 169 | carboxylic acid catabolic process (GO:0046395) | 2.53317824 |
| 170 | organic acid catabolic process (GO:0016054) | 2.53317824 |
| 171 | aerobic respiration (GO:0009060) | 2.52762974 |
| 172 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52369276 |
| 173 | actin-myosin filament sliding (GO:0033275) | 2.52151927 |
| 174 | muscle filament sliding (GO:0030049) | 2.52151927 |
| 175 | bile acid metabolic process (GO:0008206) | 2.50550122 |
| 176 | cellular amino acid catabolic process (GO:0009063) | 2.50023243 |
| 177 | sulfur amino acid biosynthetic process (GO:0000097) | 2.49661335 |
| 178 | fatty acid catabolic process (GO:0009062) | 2.49633656 |
| 179 | adenosine metabolic process (GO:0046085) | 2.49541537 |
| 180 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.48502644 |
| 181 | regulation of relaxation of muscle (GO:1901077) | 2.47199199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.40903064 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.35247102 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.90619665 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.64028378 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.44456313 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.36911010 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.14628373 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.01551221 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.99499773 |
| 10 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.85813928 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82937643 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.74950519 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.73456945 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.67490437 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.62352427 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.55905100 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.53725960 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.41724259 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36370588 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.35850225 |
| 21 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.18485431 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15091895 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11814308 |
| 24 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.03991081 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01582364 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.01387583 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.99812414 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.99074618 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.97658936 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.97573999 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96308740 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94433448 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.91563120 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88540054 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.88156073 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.84874052 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.83192861 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82935250 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77058129 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74525540 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.62087798 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61485011 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60953225 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.55482982 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.53189718 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52095710 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47328805 |
| 48 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44001301 |
| 49 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.43660795 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43494067 |
| 51 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42728826 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42631543 |
| 53 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42580544 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39697156 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37927661 |
| 56 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36412341 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.35812932 |
| 58 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.35447254 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35344747 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34210200 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34063809 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.33264693 |
| 63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32009498 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31660772 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31390260 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29465910 |
| 67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28426887 |
| 68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.27150862 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25510246 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22274166 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20847456 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20736017 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19273271 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19236283 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14292859 |
| 76 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12397591 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12040439 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11635285 |
| 79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11528042 |
| 80 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11324313 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.11162607 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08989191 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08656603 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07274680 |
| 85 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06497916 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04708549 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03612093 |
| 88 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01513351 |
| 89 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00052290 |
| 90 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99791816 |
| 91 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.99556679 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99126805 |
| 93 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98569490 |
| 94 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97714235 |
| 95 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.97125585 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95741709 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95031946 |
| 98 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94939689 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94408532 |
| 100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94096726 |
| 101 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93581483 |
| 102 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93144102 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92986892 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92146556 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91680108 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89919496 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88441621 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88366336 |
| 109 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87998488 |
| 110 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87809956 |
| 111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87556208 |
| 112 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86434182 |
| 113 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85240828 |
| 114 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.83359655 |
| 115 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.83058937 |
| 116 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.82385077 |
| 117 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.82122706 |
| 118 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81558866 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79456328 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78898174 |
| 121 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.78658882 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78588100 |
| 123 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76087227 |
| 124 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.75600173 |
| 125 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.75283697 |
| 126 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.73961897 |
| 127 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.73961561 |
| 128 | FUS_26573619_Chip-Seq_HEK293_Human | 0.73697115 |
| 129 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.70546309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.79983306 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.44666791 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.92835878 |
| 4 | MP0005365_abnormal_bile_salt | 3.45236467 |
| 5 | MP0005360_urolithiasis | 3.37273961 |
| 6 | MP0009697_abnormal_copulation | 3.29690384 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.07850519 |
| 8 | MP0000749_muscle_degeneration | 2.71156829 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.69092842 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.57698615 |
| 11 | MP0009379_abnormal_foot_pigmentation | 2.49144382 |
| 12 | MP0003195_calcinosis | 2.37197966 |
| 13 | MP0003646_muscle_fatigue | 2.33380178 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30512670 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 2.29120529 |
| 16 | MP0003252_abnormal_bile_duct | 2.21725373 |
| 17 | MP0003186_abnormal_redox_activity | 2.14479793 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 1.98530925 |
| 19 | MP0003941_abnormal_skin_development | 1.98144182 |
| 20 | MP0003111_abnormal_nucleus_morphology | 1.92615690 |
| 21 | MP0001764_abnormal_homeostasis | 1.87929411 |
| 22 | MP0005332_abnormal_amino_acid | 1.86446622 |
| 23 | MP0003077_abnormal_cell_cycle | 1.86118109 |
| 24 | MP0003718_maternal_effect | 1.79260563 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.78182183 |
| 26 | MP0002938_white_spotting | 1.73059729 |
| 27 | MP0000358_abnormal_cell_content/ | 1.70771837 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.63775886 |
| 29 | MP0001529_abnormal_vocalization | 1.63284846 |
| 30 | MP0001727_abnormal_embryo_implantation | 1.60419186 |
| 31 | MP0005330_cardiomyopathy | 1.57332578 |
| 32 | MP0005408_hypopigmentation | 1.50036612 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.49414635 |
| 34 | MP0004147_increased_porphyrin_level | 1.49018062 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.48945859 |
| 36 | MP0002090_abnormal_vision | 1.48117371 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.47696858 |
| 38 | MP0010329_abnormal_lipoprotein_level | 1.46950328 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.45368307 |
| 40 | MP0002132_abnormal_respiratory_system | 1.42545279 |
| 41 | MP0005083_abnormal_biliary_tract | 1.42495131 |
| 42 | MP0002160_abnormal_reproductive_system | 1.41194792 |
| 43 | MP0001661_extended_life_span | 1.35890049 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.32744830 |
| 45 | MP0008058_abnormal_DNA_repair | 1.31223392 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.30487157 |
| 47 | MP0005451_abnormal_body_composition | 1.28598166 |
| 48 | MP0003724_increased_susceptibility_to | 1.28534177 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.24519879 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.23862867 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.22766270 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.21754151 |
| 53 | MP0003011_delayed_dark_adaptation | 1.20536068 |
| 54 | MP0003136_yellow_coat_color | 1.20406256 |
| 55 | MP0001188_hyperpigmentation | 1.17318347 |
| 56 | MP0009840_abnormal_foam_cell | 1.14618900 |
| 57 | MP0000566_synostosis | 1.13305898 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.11813652 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.10210992 |
| 60 | MP0002163_abnormal_gland_morphology | 1.08437737 |
| 61 | MP0004233_abnormal_muscle_weight | 1.07226467 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.07212000 |
| 63 | MP0001984_abnormal_olfaction | 1.07050092 |
| 64 | MP0005253_abnormal_eye_physiology | 1.06428452 |
| 65 | MP0003828_pulmonary_edema | 1.06283394 |
| 66 | MP0002009_preneoplasia | 1.05881879 |
| 67 | MP0002972_abnormal_cardiac_muscle | 1.05249901 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.02319598 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.01599114 |
| 70 | MP0005266_abnormal_metabolism | 1.00859689 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.00446569 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.99679626 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 0.98870111 |
| 74 | MP0005385_cardiovascular_system_phenoty | 0.98870111 |
| 75 | MP0002736_abnormal_nociception_after | 0.97423883 |
| 76 | MP0000609_abnormal_liver_physiology | 0.96872710 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.96322825 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 0.96271376 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.94725575 |
| 80 | MP0004381_abnormal_hair_follicle | 0.93872191 |
| 81 | MP0001730_embryonic_growth_arrest | 0.93558792 |
| 82 | MP0001905_abnormal_dopamine_level | 0.92631931 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.92630548 |
| 84 | MP0003786_premature_aging | 0.91332832 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.90337118 |
| 86 | MP0002269_muscular_atrophy | 0.89680972 |
| 87 | MP0001835_abnormal_antigen_presentation | 0.89001839 |
| 88 | MP0008007_abnormal_cellular_replicative | 0.88210895 |
| 89 | MP0002102_abnormal_ear_morphology | 0.87985603 |
| 90 | MP0000751_myopathy | 0.87959347 |
| 91 | MP0000350_abnormal_cell_proliferation | 0.87765394 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.87471201 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.87012487 |
| 94 | MP0009764_decreased_sensitivity_to | 0.86636927 |
| 95 | MP0001542_abnormal_bone_strength | 0.85990879 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.85333375 |
| 97 | MP0005165_increased_susceptibility_to | 0.84796715 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.84447608 |
| 99 | MP0002210_abnormal_sex_determination | 0.83908776 |
| 100 | MP0002127_abnormal_cardiovascular_syste | 0.82858304 |
| 101 | MP0000747_muscle_weakness | 0.81983554 |
| 102 | MP0008057_abnormal_DNA_replication | 0.81675280 |
| 103 | MP0005367_renal/urinary_system_phenotyp | 0.80950721 |
| 104 | MP0000516_abnormal_urinary_system | 0.80950721 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.80843925 |
| 106 | MP0005389_reproductive_system_phenotype | 0.80781022 |
| 107 | MP0001293_anophthalmia | 0.80550454 |
| 108 | MP0001697_abnormal_embryo_size | 0.79850085 |
| 109 | MP0000598_abnormal_liver_morphology | 0.79309386 |
| 110 | MP0005670_abnormal_white_adipose | 0.78732280 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.78036861 |
| 112 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78014460 |
| 113 | MP0001929_abnormal_gametogenesis | 0.77376557 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.77318531 |
| 115 | MP0003868_abnormal_feces_composition | 0.76419456 |
| 116 | MP0002106_abnormal_muscle_physiology | 0.76418482 |
| 117 | MP0005410_abnormal_fertilization | 0.76191672 |
| 118 | MP0006138_congestive_heart_failure | 0.74939112 |
| 119 | MP0005171_absent_coat_pigmentation | 0.74787500 |
| 120 | MP0008932_abnormal_embryonic_tissue | 0.74739180 |
| 121 | MP0001919_abnormal_reproductive_system | 0.74738974 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74164150 |
| 123 | MP0005647_abnormal_sex_gland | 0.73774404 |
| 124 | MP0000647_abnormal_sebaceous_gland | 0.73327728 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.73019267 |
| 126 | MP0009763_increased_sensitivity_to | 0.72799065 |
| 127 | MP0004087_abnormal_muscle_fiber | 0.71646230 |
| 128 | MP0005395_other_phenotype | 0.71525025 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.71210589 |
| 130 | MP0000653_abnormal_sex_gland | 0.70099498 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.69756488 |
| 132 | MP0009643_abnormal_urine_homeostasis | 0.68733527 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.68003167 |
| 134 | MP0008469_abnormal_protein_level | 0.67686926 |
| 135 | MP0001145_abnormal_male_reproductive | 0.67436131 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.67395721 |
| 137 | MP0001853_heart_inflammation | 0.66879107 |
| 138 | MP0001324_abnormal_eye_pigmentation | 0.66621354 |
| 139 | MP0000750_abnormal_muscle_regeneration | 0.66367091 |
| 140 | MP0003693_abnormal_embryo_hatching | 0.65524330 |
| 141 | MP0001119_abnormal_female_reproductive | 0.64941982 |
| 142 | MP0010094_abnormal_chromosome_stability | 0.64675944 |
| 143 | MP0002095_abnormal_skin_pigmentation | 0.63097232 |
| 144 | MP0005369_muscle_phenotype | 0.63070979 |
| 145 | MP0001881_abnormal_mammary_gland | 0.62059130 |
| 146 | MP0000313_abnormal_cell_death | 0.60993628 |
| 147 | MP0002080_prenatal_lethality | 0.60796425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.05108786 |
| 2 | Hepatic necrosis (HP:0002605) | 4.02831877 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.86319743 |
| 4 | Acute encephalopathy (HP:0006846) | 3.83159334 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.71440735 |
| 6 | Hepatocellular necrosis (HP:0001404) | 3.68461716 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 3.61121431 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.58709120 |
| 9 | Cerebral edema (HP:0002181) | 3.57160778 |
| 10 | Renal cortical cysts (HP:0000803) | 3.51905760 |
| 11 | Increased CSF lactate (HP:0002490) | 3.50391708 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.41388595 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.26475931 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20853492 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.19918268 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.17267362 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.17168986 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.06397141 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.04400812 |
| 20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.03116907 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.96477179 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.96477179 |
| 23 | Lactic acidosis (HP:0003128) | 2.96121272 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.93091781 |
| 25 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.88498595 |
| 26 | Increased serum lactate (HP:0002151) | 2.85939031 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 2.82582334 |
| 28 | Lethargy (HP:0001254) | 2.80602656 |
| 29 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80016559 |
| 30 | Nemaline bodies (HP:0003798) | 2.79299133 |
| 31 | Hyperglycinemia (HP:0002154) | 2.78215764 |
| 32 | Hyperglycinuria (HP:0003108) | 2.77940975 |
| 33 | Joint hemorrhage (HP:0005261) | 2.77448765 |
| 34 | Abnormality of urine glucose concentration (HP:0011016) | 2.77139189 |
| 35 | Glycosuria (HP:0003076) | 2.77139189 |
| 36 | Increased muscle lipid content (HP:0009058) | 2.72127973 |
| 37 | Proximal tubulopathy (HP:0000114) | 2.71964938 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.71721967 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 2.70204826 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70204826 |
| 41 | Exercise intolerance (HP:0003546) | 2.68950941 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.67552193 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.65067295 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.63937831 |
| 45 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.59653142 |
| 46 | Hypobetalipoproteinemia (HP:0003563) | 2.57438395 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.56734824 |
| 48 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.55960449 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.55221953 |
| 50 | Methylmalonic aciduria (HP:0012120) | 2.52304901 |
| 51 | Optic disc pallor (HP:0000543) | 2.51139654 |
| 52 | Aplastic anemia (HP:0001915) | 2.50923763 |
| 53 | Leukodystrophy (HP:0002415) | 2.50592646 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.49827548 |
| 55 | Exercise-induced muscle cramps (HP:0003710) | 2.49202901 |
| 56 | Hyperammonemia (HP:0001987) | 2.47760271 |
| 57 | Exertional dyspnea (HP:0002875) | 2.45530797 |
| 58 | Methylmalonic acidemia (HP:0002912) | 2.45309275 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.42047499 |
| 60 | Microvesicular hepatic steatosis (HP:0001414) | 2.41261997 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.41034686 |
| 62 | Respiratory failure (HP:0002878) | 2.39500989 |
| 63 | Palpitations (HP:0001962) | 2.38963893 |
| 64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.37762457 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.37762457 |
| 66 | Chromsome breakage (HP:0040012) | 2.36173928 |
| 67 | Opisthotonus (HP:0002179) | 2.33399483 |
| 68 | Macrocytic anemia (HP:0001972) | 2.31285290 |
| 69 | Ketosis (HP:0001946) | 2.30565184 |
| 70 | Oral leukoplakia (HP:0002745) | 2.29967000 |
| 71 | Prolonged neonatal jaundice (HP:0006579) | 2.29276501 |
| 72 | Reticulocytopenia (HP:0001896) | 2.28638950 |
| 73 | Ventricular tachycardia (HP:0004756) | 2.28130191 |
| 74 | Lipoatrophy (HP:0100578) | 2.27383825 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 2.26931160 |
| 76 | Degeneration of anterior horn cells (HP:0002398) | 2.24712900 |
| 77 | Abnormality of the anterior horn cell (HP:0006802) | 2.24712900 |
| 78 | Hypothermia (HP:0002045) | 2.23866886 |
| 79 | Metabolic acidosis (HP:0001942) | 2.22593052 |
| 80 | Ketoacidosis (HP:0001993) | 2.21302883 |
| 81 | Nausea (HP:0002018) | 2.20176834 |
| 82 | Dilated cardiomyopathy (HP:0001644) | 2.18314701 |
| 83 | Xanthomatosis (HP:0000991) | 2.15541254 |
| 84 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.15532166 |
| 85 | Progressive muscle weakness (HP:0003323) | 2.15216405 |
| 86 | Osteomalacia (HP:0002749) | 2.14409172 |
| 87 | Calf muscle hypertrophy (HP:0008981) | 2.11082197 |
| 88 | Progressive external ophthalmoplegia (HP:0000590) | 2.10842998 |
| 89 | Renal tubular dysfunction (HP:0000124) | 2.10808574 |
| 90 | Abnormality of placental membranes (HP:0011409) | 2.08756401 |
| 91 | Amniotic constriction ring (HP:0009775) | 2.08756401 |
| 92 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07743839 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 2.07703920 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 2.07055333 |
| 95 | Respiratory difficulties (HP:0002880) | 2.05694570 |
| 96 | Multiple enchondromatosis (HP:0005701) | 2.05401389 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.02438740 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02364439 |
| 99 | Abnormality of alanine metabolism (HP:0010916) | 2.02364439 |
| 100 | Hyperalaninemia (HP:0003348) | 2.02364439 |
| 101 | Abnormality of glycolysis (HP:0004366) | 2.01880738 |
| 102 | Increased serum pyruvate (HP:0003542) | 2.01880738 |
| 103 | Neoplasm of the adrenal gland (HP:0100631) | 2.01645912 |
| 104 | Distal lower limb muscle weakness (HP:0009053) | 2.00110790 |
| 105 | Abnormality of renal resorption (HP:0011038) | 1.99328494 |
| 106 | Vomiting (HP:0002013) | 1.98930787 |
| 107 | Hypolipoproteinemia (HP:0010981) | 1.98742933 |
| 108 | Atrial fibrillation (HP:0005110) | 1.97940534 |
| 109 | Fat malabsorption (HP:0002630) | 1.97682305 |
| 110 | Pancytopenia (HP:0001876) | 1.95513303 |
| 111 | Rhabdomyolysis (HP:0003201) | 1.94796889 |
| 112 | Myoglobinuria (HP:0002913) | 1.94371390 |
| 113 | Hyperphosphaturia (HP:0003109) | 1.91980174 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91869211 |
| 115 | Cerebral palsy (HP:0100021) | 1.91672434 |
| 116 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.89950747 |
| 117 | Cerebral hypomyelination (HP:0006808) | 1.87984548 |
| 118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86571719 |
| 119 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86571719 |
| 120 | Abnormal protein glycosylation (HP:0012346) | 1.86571719 |
| 121 | Abnormal glycosylation (HP:0012345) | 1.86571719 |
| 122 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86439537 |
| 123 | Testicular atrophy (HP:0000029) | 1.85314095 |
| 124 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.84175118 |
| 125 | Subaortic stenosis (HP:0001682) | 1.84175118 |
| 126 | Sparse eyelashes (HP:0000653) | 1.83608402 |
| 127 | X-linked dominant inheritance (HP:0001423) | 1.80897261 |
| 128 | CNS demyelination (HP:0007305) | 1.80497589 |
| 129 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80211202 |
| 130 | Spastic paraparesis (HP:0002313) | 1.77702742 |
| 131 | Short tibia (HP:0005736) | 1.77051429 |
| 132 | Emotional lability (HP:0000712) | 1.74681837 |
| 133 | Conjunctival hamartoma (HP:0100780) | 1.73709644 |
| 134 | Hypoglycemic seizures (HP:0002173) | 1.68617897 |
| 135 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.68191695 |
| 136 | Medial flaring of the eyebrow (HP:0010747) | 1.67225994 |
| 137 | Megaloblastic anemia (HP:0001889) | 1.64901258 |
| 138 | Symptomatic seizures (HP:0011145) | 1.62578556 |
| 139 | Congenital, generalized hypertrichosis (HP:0004540) | 1.61174688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.12292375 |
| 2 | ZAK | 3.86172009 |
| 3 | VRK2 | 3.48242390 |
| 4 | MST4 | 3.32064117 |
| 5 | BCKDK | 3.17531800 |
| 6 | NEK1 | 3.10754080 |
| 7 | CASK | 2.73184218 |
| 8 | PDK2 | 2.39999915 |
| 9 | NME2 | 2.37524541 |
| 10 | EIF2AK1 | 2.26949508 |
| 11 | SRPK1 | 2.25067379 |
| 12 | MKNK1 | 2.24597201 |
| 13 | IRAK3 | 2.15960257 |
| 14 | MKNK2 | 2.13317064 |
| 15 | STK38L | 2.06266332 |
| 16 | MAP3K14 | 1.99941958 |
| 17 | NEK9 | 1.96973434 |
| 18 | AKT3 | 1.86298511 |
| 19 | MYLK | 1.83621024 |
| 20 | MUSK | 1.80580026 |
| 21 | OBSCN | 1.77649517 |
| 22 | TSSK6 | 1.75926683 |
| 23 | IRAK4 | 1.73467415 |
| 24 | EIF2AK2 | 1.65153243 |
| 25 | EIF2AK3 | 1.63620717 |
| 26 | BUB1 | 1.62347765 |
| 27 | CDC7 | 1.60091403 |
| 28 | PINK1 | 1.56689496 |
| 29 | PRPF4B | 1.55512907 |
| 30 | SIK3 | 1.52067579 |
| 31 | TLK1 | 1.48833309 |
| 32 | NUAK1 | 1.45170895 |
| 33 | PIM2 | 1.43089040 |
| 34 | ACVR1B | 1.37879117 |
| 35 | PLK4 | 1.31172164 |
| 36 | PIK3CA | 1.30185887 |
| 37 | SCYL2 | 1.27015158 |
| 38 | TRIM28 | 1.23342297 |
| 39 | MAP2K7 | 1.23135526 |
| 40 | MAP4K2 | 1.19414603 |
| 41 | BMPR2 | 1.16439494 |
| 42 | WNK3 | 1.16310074 |
| 43 | TESK1 | 1.16206902 |
| 44 | YES1 | 1.12709237 |
| 45 | MAPKAPK3 | 1.11561537 |
| 46 | VRK1 | 1.11476513 |
| 47 | INSRR | 1.08026552 |
| 48 | STK4 | 1.06919852 |
| 49 | SGK2 | 1.04035230 |
| 50 | TIE1 | 1.00261786 |
| 51 | LMTK2 | 0.99196669 |
| 52 | TNIK | 0.98170546 |
| 53 | IKBKB | 0.93806685 |
| 54 | TXK | 0.93387001 |
| 55 | TRPM7 | 0.90942251 |
| 56 | STK24 | 0.89901070 |
| 57 | PAK4 | 0.88246917 |
| 58 | PIK3CG | 0.86520979 |
| 59 | IKBKE | 0.84558809 |
| 60 | ADRBK2 | 0.83480378 |
| 61 | FLT3 | 0.82834728 |
| 62 | TEC | 0.82268165 |
| 63 | FRK | 0.82178110 |
| 64 | PIM1 | 0.81185292 |
| 65 | BRSK1 | 0.80466040 |
| 66 | PBK | 0.78676907 |
| 67 | ERBB3 | 0.77769497 |
| 68 | BRAF | 0.76511518 |
| 69 | TAF1 | 0.75462270 |
| 70 | IRAK1 | 0.72489522 |
| 71 | CSNK1G3 | 0.71675182 |
| 72 | PLK2 | 0.69292634 |
| 73 | DAPK1 | 0.68264457 |
| 74 | CSNK1G1 | 0.67462400 |
| 75 | CDK8 | 0.64218760 |
| 76 | AURKA | 0.63546463 |
| 77 | STK39 | 0.62546598 |
| 78 | CHUK | 0.61607760 |
| 79 | MAP3K11 | 0.61479329 |
| 80 | NLK | 0.61038089 |
| 81 | MAP3K5 | 0.60971437 |
| 82 | NME1 | 0.60967894 |
| 83 | PRKCI | 0.60650970 |
| 84 | RPS6KB2 | 0.60117174 |
| 85 | TTK | 0.59836618 |
| 86 | CSNK1G2 | 0.59515561 |
| 87 | ABL2 | 0.58587902 |
| 88 | CLK1 | 0.58508914 |
| 89 | WEE1 | 0.58387028 |
| 90 | CSNK2A1 | 0.57949994 |
| 91 | CCNB1 | 0.57512345 |
| 92 | GRK1 | 0.57199293 |
| 93 | PLK3 | 0.57154295 |
| 94 | WNK4 | 0.57096548 |
| 95 | CDK3 | 0.56526967 |
| 96 | TESK2 | 0.54691144 |
| 97 | ERBB4 | 0.54184201 |
| 98 | EPHA2 | 0.53693263 |
| 99 | DAPK3 | 0.53551769 |
| 100 | BMPR1B | 0.53085253 |
| 101 | RPS6KA5 | 0.52976152 |
| 102 | RPS6KA6 | 0.52928502 |
| 103 | ILK | 0.52694967 |
| 104 | DYRK2 | 0.52370837 |
| 105 | NEK6 | 0.52314731 |
| 106 | RPS6KB1 | 0.51915922 |
| 107 | BCR | 0.51259386 |
| 108 | TAOK3 | 0.50759632 |
| 109 | SGK223 | 0.49943674 |
| 110 | SGK494 | 0.49943674 |
| 111 | KDR | 0.49056859 |
| 112 | GRK7 | 0.48131590 |
| 113 | RPS6KC1 | 0.47774529 |
| 114 | RPS6KL1 | 0.47774529 |
| 115 | NEK2 | 0.46076586 |
| 116 | PLK1 | 0.45943875 |
| 117 | PHKG1 | 0.45749709 |
| 118 | PHKG2 | 0.45749709 |
| 119 | CHEK2 | 0.44192696 |
| 120 | TAOK2 | 0.44184980 |
| 121 | MST1R | 0.44012748 |
| 122 | PKN1 | 0.43958474 |
| 123 | PNCK | 0.43676257 |
| 124 | BRSK2 | 0.42231368 |
| 125 | OXSR1 | 0.42035784 |
| 126 | CDK19 | 0.40814298 |
| 127 | ATR | 0.40288940 |
| 128 | MAP3K12 | 0.40056561 |
| 129 | CAMK2G | 0.38156409 |
| 130 | PRKCE | 0.37973666 |
| 131 | AURKB | 0.37846357 |
| 132 | JAK3 | 0.37555474 |
| 133 | MAP2K6 | 0.35056116 |
| 134 | SGK3 | 0.34514729 |
| 135 | STK3 | 0.34489134 |
| 136 | PAK3 | 0.33110418 |
| 137 | CSNK2A2 | 0.33088386 |
| 138 | TBK1 | 0.33034461 |
| 139 | CAMK2D | 0.32978018 |
| 140 | LIMK1 | 0.32782617 |
| 141 | STK10 | 0.32551134 |
| 142 | MET | 0.31662865 |
| 143 | FER | 0.31470567 |
| 144 | CSNK1A1L | 0.29564019 |
| 145 | ATM | 0.29345199 |
| 146 | DYRK3 | 0.28772712 |
| 147 | LRRK2 | 0.28703188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.73014916 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.63171497 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18970827 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17910757 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.11391138 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.08890070 |
| 7 | Peroxisome_Homo sapiens_hsa04146 | 2.05895272 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03249632 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01103658 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00550657 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00031104 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.96723489 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 1.95987225 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95820232 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.95024303 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.88194489 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87934922 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.78914370 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.76371817 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74500063 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71367163 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67301730 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61133363 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.60966752 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58071523 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.56775424 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.55249197 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50572010 |
| 29 | Ribosome_Homo sapiens_hsa03010 | 1.47023223 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.41858780 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40242893 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39876970 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39318276 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38983987 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37449115 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.37172392 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37103439 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36224726 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33816427 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32549190 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.30159539 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30156839 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29698974 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.29242426 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.28547757 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27539662 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26817806 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 1.16893125 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16742679 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16502757 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.16409867 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16047681 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15822548 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14645530 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10016358 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 1.08295213 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04149896 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03035624 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02205051 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01788497 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00148223 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98610233 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96366509 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95179072 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93084761 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92146908 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92146274 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.90826402 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.87609096 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84248948 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84182441 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83897077 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83482678 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76770709 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.76035808 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.75852605 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72531097 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72334726 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70531878 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67673503 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.66431687 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65984663 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.65883692 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65752699 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63611821 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62265214 |
| 87 | Spliceosome_Homo sapiens_hsa03040 | 0.62089808 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59873575 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58349937 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56498129 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53032934 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51235506 |
| 93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51186300 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50772949 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45042978 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43392796 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39847284 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39740118 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.39569238 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38651893 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38364562 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36574794 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.35664597 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35510678 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34056983 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33240761 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32640723 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32388626 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30739040 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23727554 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.22959343 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20205768 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20028812 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10678524 |

